KATHLEEN SHEPPARD: Open Payments
NPI 1831384619 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 26 payments from 13 companies in 2025. Trend: 2023 $653 · 2024 $536 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $155 |
| ABBVIE INC. | 5 | $86 |
| PFIZER INC. | 4 | $76 |
| Abbott Laboratories | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Inari Medical, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Medtronic, Inc. | 1 | $17 |
Products named: Ozempic, JARDIANCE, ELIQUIS, QULIPTA, FREESTYLE LIBRE 3, TZIELD, FLOWTRIEVER CATHETER, S, Rybelsus.
Industry payments across SC — which companies pay providers there.
